G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide
G2E3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all G2E3 products
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-KIAA1333 antibody (Catalog #: ARP43228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
- Background
-
KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
Alias Symbols: FLJ20333, G2E3, PHF7B, KIAA1333
Protein Interaction Partner: LST1,WDR6,WDR6
Protein Size: 706 - Molecular Weight
- 80 kDa
- Gene ID
- 55632
- NCBI Accession
- NM_017769, NP_060239
- UniProt
- Q7L622
-
You are here:
